DECEMBER CHEMVETS LECTURE
" Reflections of Nine Years on the ACS Board"
Dr. Pat Confalone
Date: January 16, 2017
Time: 7 p.m. – 9:30 p.m.
Location: DuPont Country Club, Wedgewood Room
It has been an honor and privilege to serve three terms on the American Chemical Society’s Board of Directors, the last three years as Chair. The experience began in 2009 in the midst of the financial crisis, which threatened the solvency of the Society. Fortunately, after many difficult actions were taken, the Board was able to focus on the many wonderful and important programs that the ACS offers to its members and the greater chemical enterprise. Our advances in education, globalization, entrepreneurship, career assistance, public outreach, government affairs, strategic planning, national and regional meetings, awards programs, and other topics will be discussed. The challenges and opportunities of our information units ACS Publications and Chem Abstracts will be outlined. Finally, our initiatives to streamline and simplify governance structure and processes to afford a more agile Society will be presented.
A graduate of M.I.T., Pat obtained a Ph.D. at Harvard with Nobel laureate Prof. R.B. Woodward. After a post-doctoral stint, also with Prof. R.B. Woodward, directed toward the total synthesis of Vitamin B12, he joined the Chemical Research Department of Roche Pharmaceuticals. Moving to DuPont Central Research, his Bioorganic Chemistry group developed the fluorescent dye-labeled reagents that were used in automated DNA sequencing, eventually employed in the human genome project. With DuPont’s Pharmaceutical Division, Pat’s Medicinal Chemistry department discovered Cozaar™, a major anti-hypertensive based on angiotensin II antagonism. After 22 years in Discovery Research, he then directed pre-clinical development with Process R&D which carried out the chemical development of Cozaar™ and Sustiva™, a highly successful therapeutic used to treat AIDS, currently in over 5 million patients. As Vice President, Global R&D, DuPont Crop Protection, he led 200 scientists to build a world class pipeline of novel products, including Rynaxypyr™, the world’s safest insecticide, with world-wide sales over a billion dollars a year. He has presented g 110 invited or plenary lectures worldwide, published g 140 papers, obtained g 50 U.S. Patents, and has been an associate editor of over ten peer-reviewed scientific journals. He has received numerous honors and awards, including the Harvard Graduate Society Prize, the Alpha Chi Sigma Award, the Robert A. Welch Lectureship, and the Philadelphia Organic Chemistry Award. He was nominated to the Harvard Society of Fellows, is an elected Fellow of the American Association for the Advancement of Science, and was Chairman of the Board of the American Chemical Society. Currently, Pat is an independent consultant to the agrichemical, biotechnology, and pharmaceutical industries.